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LOW-DOSE NONLINEAR EFFECTS OF SMOKING ON CORONARY HEART
DISEASE RISK
Louis Anthony (Tony) Cox, Jr.  Cox Associates
 Some recent discussions of adverse human health effects of active and passive smok-
ing have suggested that low levels of exposure are disproportionately dangerous, so that
“The effects of even brief (minutes to hours) passive smoking are often nearly as large
(averaging 80% to 90%) as chronic active smoking” (Barnoya and Glantz, 2005). Recent
epidemiological evidence (Teo et al., 2006) suggests a more linear relation. This paper
reexamines the empirical relation between self-reported low levels of active smoking and
risk of coronary heart disease (CHD) in public-domain data from the National Health and
Nutrition Examination Survey (NHANES). Consistent with biological evidence on J-
shaped and U-shaped relations between smoking-associated risk factors and CHD risks, we
find that low levels of active smoking do not appear to be associated with increased CHD
risk. Several methodological challenges in epidemiology may explain how model-derived
estimates can predict low-dose linear or concave dose-response estimates, even if the
empirical (i.e., data-based) relation does not show a clear increased risk at the lowest
doses.
Keywords: Coronary Heart Disease (CHD), hormesis, U-shaped, J-shaped, empirical dose-response
model, confounding, modeling bias, classification tree analysis
INTRODUCTION: DOES HORMESIS FAIL FOR SMOKING AND
CORONARY HEART DISEASE?
An emerging working hypothesis for some toxicologists and risk asses-
sors is that many – perhaps most – biological dose-response relations
exhibit J-shaped or U-shaped regions at low doses. That is, probability of
harm (or, more generally, of exposure-related departures of variables
from their “normal” levels) decreases with increasing dose at sufficiently
small exposure levels, even if it increases with increasing doses at higher
exposure levels. When this pattern holds, responses to low levels of expo-
sures cannot necessarily be extrapolated from observed dose-response
relations at higher doses.
Although considerable empirical support has been advanced in sup-
port of this “hormesis” hypothesis (Calabrese and Baldwin, 2001), the
universality of its application is still being assessed. The shape of dose-
response functions for complex mixtures, such as diesel exhaust or ciga-
rette smoke, can potentially be especially valuable in either supporting
the hormesis hypothesis or in understanding how it breaks down.
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In contrast to hormesis, studies of environmental tobacco smoke
(ETS) suggest that its effects on risks of diseases such as CHD are much
larger than would be expected based on associations in active smokers
exposed to much higher doses. Although some commentators have con-
strued this mismatch as suggesting that perhaps reported ETS-CHD asso-
ciations reflect incompletely controlled confounders or statistical model-
ing biases (e.g., Nilsson, 2001), others suggest that active smokers might
have adaptive responses that create less-than-proportional increases in
CHD risk at relatively high exposure levels compared to the increases in
risks experienced by non-smokers from relatively low ETS exposures
(Glantz and Parmley, 1991; Wells, 1994; Law et al., 1997; Law and Wald,
2003). For example, it has been stated that “Evidence is rapidly accumu-
lating that the cardiovascular system – platelet and endothelial function,
arterial stiffness, atherosclerosis, oxidative stress, inflammation, heart rate
variability, energy metabolism, and increased infarct size – is exquisitely
sensitive to the toxins in secondhand smoke. The effects of even brief
(minutes to hours) passive smoking are often nearly as large (averaging
80% to 90%) as chronic active smoking” (Barnoya and Glantz, 2005). If
true, this provides an important counter-example to the hormesis hypoth-
esis for smoking and CHD risk.
This paper reexamines the empirical relation between relatively low
levels of active smoking and CHD risks. It seeks to reassess whether the
hypothesis of hormesis must be rejected in this context. A key method-
ological challenge is that selecting particular statistical and epidemiolog-
ical modeling assumptions can strongly affect the results obtained and
the resulting interpretation of available low-dose smoking-CHD data, sug-
gesting a need for multibias modeling (Greenland, 2005). To address this
challenge, we consider non-parametric techniques for identifying possi-
bly nonlinear dose-response relations in large epidemiological data sets.
The following sections briefly review key results from the relevant epi-
demiological and biological literatures and then present a new analysis of
a publicly available data set, the National Health and Nutrition
Examination Survey (NHANES) study, that provides data on active smok-
ing and CHD risks, among other outcomes.
PREVIOUS FINDINGS AND NEED FOR IMPROVED METHODS TO
QUANTIFY LOW-DOSE EFFECTS OF SMOKING ON CHD RISK
Since the 1960s, the relation between risk of coronary heart disease
and exposures to relatively low levels of active cigarette smoking (e.g.,
five or fewer cigarettes per day) or environmental tobacco smoke (ETS)
has been examined in dozens of studies and hundreds of publications,
resulting in diverse epidemiological and biomedical findings, data inter-
pretations, meta-analyses, and reviews. Table 1 summarizes examples of
various conclusions from studies on ETS and CHD risk. Some studies
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TABLE 1. Examples of Reported Findings on ETS and CHD Risk 
Study Findings*
Chen et al., 2004 “When all CHD categories are combined there is a regular, signifi-
cant gradient [dose-response for ETS and CHD]... [But] there was
a higher prevalence of questionnaire angina, undiagnosed CHD,
and all CHD in subjects with no detectable cotanine...”
Enstrom and Kabat, 2003 “For participants followed from 1960 until 1998 the age adjusted
relative risk (95% confidence interval) for never smokers married
to ever smokers compared with never smokers married to never
smokers was 0.94 (0.85 to 1.05) for coronary heart disease...No sig-
nificant associations were found for current or former exposure to
environmental tobacco smoke before or after adjusting for seven
confounders.”
Nilsson, 2001 “By pooling data from 20 published studies on ETS and heart dis-
ease, some of which reported higher risks than is known to be
caused by active smoking, a statistically significant association with
spousal smoking is obtained. However, in most of these studies,
many of the most common confounding risk factors were ignored
and there appears to be insufficient evidence to support an associ-
ation between exposure to ETS and CHD.”
Law et al., 1997 “Cohort and case control studies show a 30% excess risk of
ischemic heart disease in nonsmokers whose spouses smoke com-
pared with that in nonsmokers whose spouses do not smoke.
There is a nonlinear dose-response; the excess risk from actively
smoking 20 cigarettes/day is only 80%. ...In experimental studies
passive and active smoking have similar effects on platelet aggrega-
tion. The collective evidence supports a significant effect of low
dose tobacco smoke exposure in causing ischaemic heart disease.”
Steenland et al., 1996 “Results are consistent with prior reports that never-smokers cur-
rently exposed to ETS have about 20% higher CHD death rates.
However, our data do not show consistent dose-response trends
and are possibly subject to confounding by unmeasured risk fac-
tors.”
Gori, 1995 “Numerous epidemiologic studies report that the active smoking
of less than 10 cigarettes/day is not associated with measurable
risk of coronary heart disease (CHD). Thus, even assuming that
ETS and MS [mainstream] have equivalent biologic activities, con-
ceivable ETS doses to nonsmokers are far below apparent no-
effect thresholds for active smoking.”
Wells, 1994 “The effects of passive smoking on ischemic heart disease are
reviewed. Short-term exposures of 20 min to 8 h result in
increased platelet sensitivity and decreased ability of the heart to
receive and process oxygen. Longer term exposure results in
plaque buildup and adverse effects on blood cholesterol. The
available epidemiology is reviewed, and it is concluded that passive
smoking increases the coronary death rate among U.S. never
smokers by 20% to 70%.”
Glantz and Parmley, 1991 “Nonsmokers appear to be more sensitive to ETS than do smok-
ers, perhaps because some of the affected physiological systems are
sensitive to low doses of the compounds in ETS, then saturate, and
also perhaps because of physiological adaptions smokers undergo
... These results suggest that heart disease is an important conse-
quence of exposure to ETS.”
*All emphases added.
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have reported elevated risks even at the lowest doses studied (e.g.,
Njolstad et al., 1996 for 1-9 cigarettes per day in a Norwegian popula-
tion), while others have reported either no detected independent effect
of smoking on CHD risks (Chien et al., 2005 for a community in Taiwan)
or elevated risks only for smoking exposures above a threshold, such as
20 pack-years (Lee et al., 2001, for Chinese, Malay, and Asian Indian
males in Singapore).
Evidence of Hormesis for Smoking and CHD Risk Factors
Several biological mechanism have been proposed for how low-level
or second hand smoke exposure can increase CHD risk. However, care-
ful reviews of the relevant biology (e.g., MacCallum, 2005) indicate that
many of the biological effects of smoking are associated with – but do not
necessarily cause – increased CHD risk. These effects may serve as bio-
markers of exposure and of CHD risk, but without necessarily constitut-
ing causal mechanisms implying that exposure increases risk. For exam-
ple, “Despite their evident importance in MI [myocardial infarction], it
has proven difficult epidemiologically to demonstrate associations
between platelet properties and CHD events in prospective studies”, per-
haps because of measurement difficulties and uncertainties
(MacCallum, 2005, p. 37). Similarly, is not clear whether much-discussed
markers such as C-reactive protein (CRP) actually cause any increases in
CHD risk, although CRP is predictive of CHD risk – perhaps because it is
caused by other conditions that also cause increased CHD risk (e.g.,
Miller et al., 2005).
Many important biological variables that are related to smoking
and/or CHD risk have been found to exhibit hormetic (U-shaped or J-
shaped) relations with CHD risk (and, in many cases, with all-cause mor-
tality risk). Examples include: C-reactive protein (O’Callaghan et al.
2005), total and low-density lipoprotein cholesterol in a prospective study
among elderly men (Curb et al., 2004); serum insulin levels in a cross-sec-
tional survey of 500 men and 500 women aged 40-79 years in Italy
(Bonora et al., 1998); blood pressure in the first two years following MI in
men 45-57 years old (Flack et al., 1995); hematocrit among women in the
Framingham heart study (Gagnon et al., 1994); and possibly heart rate for
sudden CHD death, although the evidence for this is mixed (Dyer et al.,
1980). Thus, even bearing in mind that subgroup analyses can create false
positives (Brookes et al., 2001), it appears that current biological knowl-
edge of CHD etiology allows the possibility of a U-shaped or J-shaped rela-
tion between exposures (including smoking) that affect one or more of
these variables (Hatsukami et al., 2005) and resulting risks of CHD.
Therefore, empirical assessment of the true shape of the low-dose dose-
response relation based on epidemiological data remains an important
and worthwhile challenge.
L. A. Cox, Jr.
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EMPIRICAL ASSESSMENT OF THE LOW-DOSE RELATION BETWEEN
SMOKING AND CHD RISK IN THE NHANES STUDY
To investigate the empirical (i.e., data-driven) shape of the relation
between relatively low exposures to cigarette smoking and resulting risk of
CHD without making any strong a priori parametric modeling assumptions,
we downloaded survey data from the National Health and Nutrition
Examination Survey (NHANES) study for 2001-2002 (on-line at www.cdc.gov/
nchs/about/major/nhanes/nhanes01-02.htm#Examination%20Files). As
emphasized in the Analytic Guidelines for this survey, NHANES is a com-
plex survey sample, and careful attention to weighting is needed to under-
stand, interpret, and generalize from it to other (e.g., national) populations.
However, in the analyses in this section, we only use conditional (internal to
the survey data set) relations between smoking levels and CHD risks. These
conditional relations can be obtained directly from the survey data, and no
attempt to generalize to other populations is made here.
Figure 1A plots the mean proportions (and 95% binomial confidence
intervals) of subjects who answered “Yes” to the question “Has a doctor or
Nonlinear smoking effects on CHD risk
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FIGURE 1. A: CHD Risk vs. Self-Reported Smoking Levels in the NHANES Survey. Each positive num-
ber on the x axis represents the range of values that are closest to it. “45” is a code for “more than 40”.
B: Nonparametric Regression of CHD Risk vs. Cigarettes/Day. C: Polynomial Regression of CHD Risk
vs. Cigarettes/Day. Dashed lines indicate approximate lower and upper 95% confidence limits. 
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other health professional ever told you [or subject] that {you/s/he} had
coronary heart disease?” as the dependent variable (vertical axis). Self-
reported smoking level is the explanatory variable (horizontal axis). The
data in the plot suggest no clear increase in CHD risk at relatively low lev-
els of smoking exposure. (Breaking down the subjects by sex and by age
groups, such as 65 or older vs. younger, does not change these conclu-
sions.) Figure 1B shows a nonparametric regression curve (fit by distance-
weighted least squares) used to smooth the scatter plot of CHD risk indi-
cator values (0 = no, 1 = yes) vs. cigarettes per day. Figure 1C fits a poly-
nomial (quadratic) regression curve to the same data. In this parametric
model, the nonlinear (J-shaped) quadratic term is statistically significant.
The estimated minimum risk occurs at about 11 cigarettes per day, con-
sistent with earlier findings in multiple data sets (reviewed in Gori, 1995)
of no apparent significant increase in CHD risk among smokers of 10 cig-
arettes per day or less.
Definition of the “zero” exposure level plays a potentially important
role in such statistical modeling of low-dose effects. In these figures, the
“0” level was reserved for subjects who reported not having smoked more
than 100 cigarettes throughout their lives (and who report being non-
smokers now.) This exposure category may be associated with other
behaviors (e.g., healthy diet, exercise, etc.) that confound the effects of
the zero smoking level. Nonetheless, Figure 1 suggests that, while 40 or
more cigarettes per day is clearly associated with a significantly increased
CHD risk, there is no such clear, significant increase at the lowest report-
ed levels.
Figure 2 repeats the preceding analysis for ex-smokers who report
having smoked at least 1 cigarette per day when they used to smoke.
Again, the main conclusion from these plots is that, for relatively low level
of past smoking (e.g., below 10 cigarettes per day), higher reported num-
bers of cigarettes per day do not appear to be associated with increased
CHD risk; to the contrary, a U-shaped pattern appears to be possible.
The nonlinear dose-response relations suggested in these figures may
not reflect a true cause-and-effect relation, but rather the effects of con-
founders (such as alcohol and coffee consumption, which, as noted pre-
viously, are associated with cigarette consumption and also have U-shaped
relations with CHD risk) or other variables associated with both smoking
and CHD risks.
DISCUSSION
The following paragraphs summarize technical issues that can drive
differences in conclusions between epidemiological studies such as those
in Table 1. These threats to valid inference must be overcome to create
defensible estimates of dose-response relations from epidemiological data.
L. A. Cox, Jr.
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Model Form Selection
The choice of a statistical model constrains what it can reveal about
low-dose effects of exposures. For example, many investigators have
relied on specific parametric or semi-parametric models (e.g., logistic
regression or Cox proportional hazards models) to interpret epidemio-
logical data on smoking exposures and CHD risks. Such models imply
that model-estimated risks must be elevated at low doses if they are ele-
vated at high doses, whether or not this is what the data show. Some epi-
demiological studies that have reported elevated risks at relatively low
exposure levels (e.g., Njolstad et al., 1996) have done so based on such sta-
tistical model implications.
Older analyses that report raw data rather than such statistical model-
based estimates can show patterns for CHD risks at low exposure levels strik-
ingly different from the elevated risks predicted by statistical models that
assume a single set of coefficients for all exposure levels. For example,
Freund et al. (1993)’s analysis of Framingham Heart Study data (their Table
2) shows CHD rates that are lower among men who smoke 1-10 cigarettes per
Nonlinear smoking effects on CHD risk
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FIGURE 2. A: CHD vs. Past Smoking of 1-20 cigarettes per day. B: Nonparametric Regression, CHD vs.
Past Smoking of 1-20 cigarettes per day. C: Polynomial Regression CHD vs. Past 1-20 cigarettes per day. 
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day than among never-smokers, for both age groups considered. Similarly,
Bush and Comstock (1983) show reduced risks of CHD in the lowest expo-
sure group considered (smokers of 1-9 cigarettes per day) in each of three
age groups examined (25-44 years, 45-64 years, and 65-74 years) in a study
of smoking and CHD mortality risks in women, even after adjusting for vari-
ables (e.g., marital status, education, housing quality, and frequency of
church attendance) that have been associated with CHD risk in other data
sets. Jenkins et al., (1968, Table 1 and 2) show a slightly smaller rate of CHD
cases among smokers of 1-15 cigarettes per day than among non-smokers
(12.2 vs. 13.3 per 1000 men per year) for men aged 50-59 years at study
intake, but a greater rate of CHD cases among smokers of 1-15 cigarettes per
day than among non-smokers (5.3 vs. 3.7 per 1000 men per year) for men
aged 39 to 49 at study intake. The reported results do not have enough res-
olution to examine rates specifically for 1-10 cigarettes per day to allow com-
parison with the results of Freund et al. (1993), but it seems plausible that
CHD risks could be elevated among smokers of 10 or more cigarettes per
day, even if not among smokers of fewer than 10 cigarettes per day (the
apparent threshold for detectably elevated risk mentioned by Gori, 1995.)
Variable Selection
An enduring challenge in multivariate risk modeling is selection of vari-
ables to include in the final model. Different logistic regression models that
appear to make equally statistically valid selections of predictor variables
can give very inconsistent predictions for outcomes such as mortality fol-
lowing MI (Steyerberg et al., 2004). Automated variable-selection tech-
niques can result in models that are unstable and not reproducible (e.g.,
across bootstrap samples of the original data set) (Austin and Tu, 2004),
while manual selection of variables by investigators, especially with precon-
ceived theories, may lead to biased conclusions and to errors that are not
readily apparent based on standard statistical tests (e.g., Greenland, 2005).
Empirically, a study that applied several variable-selection algorithms
(including logistic regression with forward or backward stepwise variable
selection; neural networks; self-organizing maps; and rough sets) to the
same data set of 500 records with 45 predictor variables from patients with
chest pain, and a dichotomous dependent variable indicating whether
myocardial infarction (MI) occurred, showed that the different variable-
selection methods yielded inconsistent results. Only one variable out of
45 (ST elevation) was selected by all methods. Only two out of eleven vari-
able-selection methods (one of which was expert cardiologist opinion)
identified smoking as a useful predictor of MI risk for patients in this data
set (Dreiseitl et al., 1999). Such inconsistencies may help to explain dif-
ferences in conclusions and reported associations among studies that use
different methods of variable selection.
L. A. Cox, Jr.
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Variable Coding
How continuous variables are coded into discrete ranges or levels can
also affect statistical conclusions about associations. For example, as men-
tioned above, Jenkins et al. (1968) found evidence of a dose-response rela-
tion for CHD risk that progressively increases with increasing dose in the
younger of two age-groups analyzed, taking 1-15 cigarettes/day as the low-
est range considered; but Bush and Comstock (1983) showed reduced
risks of CHD in all age groups analyzed, taking 1-9 cigarettes/day as the
lowest range considered. The reported findings may be sensitive to the
modelers’ choices of how to bin the exposure and covariate data. (For
this reason, it is often recommended in modern statistical and epidemio-
logical methodology that continuous variables should not be artificially
coded into discrete levels; see e.g., Stromberg, 1996; Royston et al., 2006).
Confounding
The etiology of CHD is complex and still imperfectly elucidated. A sur-
prising variety of risk factors can potentially act as confounders, associated
both with smoking and with increased CHD risk. Studies in multiple coun-
tries have shown that many risk factors (e.g., low exercise, poor diet, high
body fat, high blood pressure, low concentration of high density choles-
terol, low income, low education, low cognitive performance) tend to clus-
ter with each other and with both smoking and CHD risk in the same indi-
viduals, often starting relatively early in life (e.g., by adolescence) and per-
sisting thereafter (e.g., Ebrahim et al., 2004.) Smoking is positively associ-
ated with coffee and alcohol consumption, both of which have been
reported to have hormetic (J-shaped or U-shaped) dose-response relations
with CHD risk (Kleemola et al., 2000; Murray et al., 2002).
Various psychosocial factors are also strongly and independently asso-
ciated with both smoking and with increased CHD risk (Albus et al.,
2004). Depression is associated with increased levels of coagulation fac-
tors VII and X (Doulalas et al., 2005) and also with smoking (e.g.,
Kavanaugh et al., 2005 for mothers in the United States). Low socioeco-
nomic status (SES) indicators are strongly associated with increased risk
of CHD, as well as with smoking; however, smoking does not appear to
explain away the causal relation between low SES over time and increased
CHD risks (Lawlor et al., 2005a). Possible biological mechanisms suggest-
ed for the low SES-increased CHD risk relations include increased levels
of inflammatory cytokines and plasma fibrinogen levels among lower-SES
subjects (Steptoe et al., 2002, 2003). However, adjusting for life course
socioeconomic position attenuates the association between both fibrino-
gen and C-reactive protein and CHD risk in British women, but not the
relation between smoking and CHD risk, suggesting that the latter but
not the former may be causes of increased CHD risk (Lawlor et al., 2005b)
Nonlinear smoking effects on CHD risk
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Among CHD patients, low SES is associated with both increased levels of
high-sensitivity C-reactive protein (a marker of systemic inflammation)
and poorer health outcomes (Lubbock et al., 2005).
Many commentators (e.g., Law et al., 1997, Law and Wald, 2003;
Pechacek and Babb, 2004) conclude that confounding can account for at
most only a small portion of the association between smoking and CHD
risk. Others have suggested that the contribution may be much larger and
that, in conjunction with modeling biases, incompletely controlled con-
founding may explain away most or all of the commonly reported associ-
ations between ETS exposures and CHD risk (e.g., Gori, 1995; Nilsson,
2001). As in other areas of epidemiology (Greenland, 2005), different
treatments of confounding and modeling biases may help to explain sig-
nificant differences in findings.
Measurement Errors and Misclassification Biases
Survey subjects often round their responses to convenient numbers,
such as multiples of 5 or 10, and even these rounded numbers sometimes
reflect wishful thinking. The gap between reported and true exposure
numbers (or between reported and true exposure categories, in categor-
ical data analyses) may induce large, systematic biases in the results of sta-
tistical analyses that ignore such measurement errors and misclassifica-
tion errors (Hofler, 2005; Fox et al., 2005).
Which is more likely: that a smoker of 8 cigarettes per day will round
down to 5 or up to 10 in answering survey questions? Is misreporting 10
cigarettes per day as 5, or misreporting 5 cigarettes per day as 10, the
more common error? The answers to such questions may affect the
shapes of dose-response relations estimated from self-reported exposure
data. If there is a systematic bias toward under-estimating reported ciga-
rette consumption rates, then effects from higher smoking rates will tend
to be attributed to lower levels of smoking.
In much past literature on smoking exposure and CHD risks, para-
metric or semi-parametric statistical models (such as logistic regression or
proportional hazards models, respectively) have been used to estimate
dose-response relations and associations without explicitly modeling
effects of exposure estimation and reporting errors. This can introduce
large biases (in either direction) into estimated associations and effects
(Luan et al., 2005; Hu et al., 1998). It tends to increase the rate of false-
positive findings for associations (e.g., between low levels of smoking and
CHD risks) by artificially narrowing confidence intervals. Both individual
studies and meta-analyses based on them are subject to biases and infla-
tion of false positives when exposure estimation errors are ignored unless
appropriate sensitivity analyses and/or corrections are performed (Fox et
al., 2005).
L. A. Cox, Jr.
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CONCLUSIONS
This paper has examined data on the relation between low levels of
active smoking and risk of coronary heart disease, with attention to
whether existing data conclusively refute the general hypothesis of
hormesis for smoking and CHD risk. A review of previous epidemiologi-
cal literature on active smoking and CHD risks indicates that smokers of
relatively few (e.g., less than 10) cigarettes per day do not appear to suf-
fer significantly increased CHD risks, and in some cases may even have
smaller CHD risks than non-smokers. Interpretation of the data is com-
plicated by the finding that smoking is significantly associated with other
behaviors (e.g., alcohol and coffee consumption) that have been report-
ed as having J-shaped or U-shaped relations with CHD risks (Kleemola et
al., 2000; Murray et al., 2002.)
The papers on active and passive smoking that we have reviewed,
including meta-analyses and review papers as well as individual studies
(see e.g., Table 1), generally have not corrected systematically and thor-
oughly for potential biases due to model form selection, variable selec-
tion, variable coding, confounding, and errors in exposure estimates,
although appropriate statistical methods for doing so have been devel-
oped (Ricci and Cox, 2002; Greenland, 2005). Such uncorrected biases
may help to explain differences in conclusions and interpretations of
data across studies.
To avoid potential biases due to model form selection, we examined
the shape of the dose-response relation for active smoking and CHD risks
in the NHANES data set, without using parametric models to smooth
(and perhaps distort) response data at the lowest exposure levels using
data collected at higher exposure levels. The major finding, shown in
Figures 1 and 2, is that the empirical relations we found in this data set
do not appear to refute the possibility of hormesis. Nor do they support
the reverse hypothesis, that low levels of exposure are disproportionately
hazardous compared to higher levels of exposure (super-linear dose-
response). This is partly consistent with a recent large multinational study
of acute myocardial infarction risk (Teo et al., 2006, Table 4) that found
odds ratios increasing approximately linearly with cigarettes per day (with
statistically significant increases noted at reported smoking levels as low
as 3-4 cigarettes per day). However, for the dependent variable examined
in this paper (answering “Yes” to the question “Has a doctor or other
health professional ever told you [or subject] that {you/s/he} had coro-
nary heart disease?”), no significant increase in risk is apparent at the low-
est levels of smoking (Fig. 1).
Finally, we reviewed relevant biological literature and noted evidence
of U-shaped and J-shaped relations between several important smoking-
related risk factors (and/or biomarkers) and CHD risks (e.g., Bonora et
al., 1998; Curb et al., 2004; Dyer et al., 1980; El-Khairy et al., 2001; Flack et
Nonlinear smoking effects on CHD risk
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al., 1995, Gagnon et al., 1994; Iribarren et al., 1996). Such studies suggest,
but do not prove, that the appearance of reduced risks at low levels of
smoking exposure may be caused in whole or in part by confounding due
to relatively low levels of other risk factors at these low levels of smoking.
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